A pilot study to determine the test characteristics of serum soluble FMS-like tyrosine kinase in control patients, patients with chronic hypertension, patients with gestational hypertension, and preeclamptic patients.

***Note: Comments about this teaching resource, its content, and your thoughts can be made on this website (by registered users) or on Facebook (all users).

Estimated Time to View: 35 minutes
Target Audience: Fellows, Faculty
Title: Diagnostic Utility of solube FMS-like tyrosine kinase 1 and soluble endoglin in hypertensive diseases of pregnancy
Citation: American Journal of Obstetrics and Gynecology 2007, Volume 197, pp. e1-28.e6
Date Created: 2007
Revisions: None Indicated
Disclaimers: None
Resource Type: Text
Recommend to a Colleague/Friend
sflt-table2 sflt-abstract1

Transparent Peer Review

[starratingmulti id=”3″] To learn more about our 6-point transparent peer review system, click here



You must be logged in to post a comment.




Speak your mind

  • Nephrology On-Demand Plus

    Our full-featured iOS app for the iPhone and iPad. NOD + integrates
    1. kidney education,
    2. training, and
    3. recruitment

    into a streamlined and user-friendly interface.


  • Kidney Konnection

    A newsletter that discusses sophisticated topics in Nephrology for physicians in Internal Medicine.
    Click here to access your complimentary subscription